PAHCPhibro Animal Health Corporation
−1.3% today · −8.0% over a year
4/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 57% of the instruments we score
Trend: among the weakest; priced lower than most peers. Dividend yield 1.27%.
Phibro Animal Health Corporation (PAHC) belongs to the Health care sector and is listed on Nasdaq; country: United States. Its market value is about €1.4B. Over the past 12 months the price changed by −8.0%, with an annualised volatility of 55% and a largest fall of 52%. The dividend has been raised 12 years in a row.
Smart Score
How it is scored →The Smart Score (1–10) describes how this instrument compares with its peers on published, rules-based measures of value, quality, trend, stability and dividend safety. It is not a forecast and not personal advice.
Compared with: Health care companies in USA (n = 337)
Current rating first published: · last recomputed · rating log
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Accrualsweighs on the score · better than 8% of peers
- EBIT / EVsupports the score · better than 95% of peers
- 12-month trend (ex last month)weighs on the score · better than 24% of peers
Red flags and notes
- Caution. Accruals or the Beneish M-score are in the watch zone. More in the glossary → Accruals or the Beneish M-score are in the watch zone.
- Caution. Dividends exceed earnings or free cash flow. More in the glossary → Dividends exceed earnings or free cash flow.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/E
- 15.6
- P/B
- 4.0
- P/S
- 1.0
- EV/EBIT
- 11.4
- Free-cash-flow yield
- 0.6%
- Market cap (EUR)
- €1.4B
Profitability and debt
- Return on equity
- 29.7%
- Return on invested capital
- 14.8%
- Gross margin
- 33.8%
- Net debt / EBITDA
- 2.67
Dividends
- Dividend yield
- 1.27%
- Payout ratio
- 20%
- 5-year dividend growth (per year)
- 0.0%
- Years of dividend growth
- 12
Returns and risk
- 1 day
- −1.3%
- 1 month
- +6.1%
- 1 year
- −8.0%
- Volatility, 1 yr
- 55.3%
- Max drawdown, 1 yr
- −52.1%
- Beta
- 0.73
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| AGLagilon health inc. | 1/10 | 0.0% | 298.2% |
|---|---|---|---|
| INVAInnoviva Inc | 9/10 | 0.0% | 19.4% |
| REPLReplimune Group Inc. | 1/10 | 0.0% | 53.7% |
| ANABAnaptysBio Inc | —/10 | 0.0% | 109.5% |
| OCULOcular Therapeutix Inc. | 1/10 | 0.0% | −36.8% |
| NUVBNuvation Bio Inc. | 1/10 | 0.0% | −14.5% |
| ANIPANI Pharmaceuticals Inc | 8/10 | 0.0% | −23.1% |
| SNDASonida Senior Living Inc. | —/10 | 0.0% | 28.4% |
News and filings
- PHIBRO ANIMAL HEALTH CORP: 8-K — Results of operations
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 27 Aug 2026
- PHIBRO ANIMAL HEALTH CORP: 10-K — Annual report for the period ending 30 Jun 2026
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 27 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 1 entry
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| First rating | 4/10 | 4 · 1 | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.